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 Abnormalities in the amygdala, a structure centrally associated with emotional 
processing, have been suggested as a neurobiological substrate of the socio-emotional deficits 
observed in autism spectrum disorders (ASD). Moreover, youth with ASD are at increased risk 
for anxiety disorders, possibly due to socio-emotional impairments. Using measurements from 
magnetic resonance imaging (MRI), as well as the Multidimensional Anxiety Scale for Children 
(MASC), I compared amygdala volume and anxiety levels between youth with ASD and healthy 
controls, aged 8-19 years. Relative to controls, participants with ASD displayed significantly 
larger bilateral amygdala volumes, as well as higher levels of social and separation anxiety. A 
significant interaction between group, social anxiety, and amygdala volume was present within 
the ASD group, driven by a positive correlation between social anxiety scores and bilateral 
amygdala volumes. No relationships between amygdala volume and anxiety were found in 
controls. These results suggest that within ASD, larger amygdala volume is associated with a 
higher degree of social anxiety.  
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Larger Amygdala Relates to Social Anxiety in Youth with Autism Spectrum Disorders 
Autism Spectrum Disorders (ASD) are associated with impaired socio-emotional 
understanding, reciprocation, and communication (APA, 2000). It has been suggested that 
abnormalities in the amygdala, a structure regarded as an underlying component to socio-
emotional cognition, play a necessary role in the social deficits observed in ASD (Baron-Cohen 
et al., 2000).  
Amygdala Abnormalities 
Numerous MRI studies have found abnormal amygdala structure in autism. Evidence of 
the extent of these abnormalities, however, has remained relatively inconsistent. Previous 
findings suggest that young children with ASD evince significantly larger amygdala volume 
(Nordahl et al., 2012; Sparks et al., 2002). Similar results have been found in adolescents, as well 
as in adults with high-functioning autism (Buitelaar, Groen, Teluij, & Tendolkar, 2010; Howard 
et al., 2000). However, others have found increased amygdala volumes in childhood, which 
significantly decrease into adolescence (Schumann et al., 2004), and decreased limbic volumes 
in both adolescents and adults (Aylward et al., 1999). Inconsistencies in previous findings may 
possibly be due to the various age groups studied, as well as disparate sample sizes (for instance, 
85 participants with ASD aging 2-4 in Nordahl et al., 2012; 10 participants with ASD ranging 
15.8-40.3 years in Aylward et al., 1999).  
Age and Development 
Although the amygdala continues to develop throughout the first two decades of life, 
children with ASD may reach abnormally large volumes, which appear to cease in late childhood 
and decrease into adolescence and adulthood. (Schumann et al., 2004). Similar growth 
trajectories have been found in the cortex as well. Courchesne and colleagues (2001) found a 
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quadratic relationship between cerebral cortical gray matter and age, which was present in 
controls but much more pronounced in autism. Youth with ASD displayed an initial neural 
overgrowth, which ‘peaked’ earlier in childhood and decreased to reach similar, and eventually 
lower volumes, relative to controls. If there is in fact a nonlinear relationship between amygdala 
volume and age, anatomical studies performed on youth with restrictive age ranges may yield 
conflicting results. 
Anxiety 
Along with neuroanatomical changes, late childhood and adolescence presents a large 
number of cognitive and social transitions. Vulnerabilities to emotional disorders increase, 
especially in those with ASD. Anxiety is notably prevalent in ASD, and may worsen throughout 
adolescence (Kuusikko et al., 2009; Ollendick, Oswald, Scahill, & White, 2009). Although 
anxiety has long been associated with ASD (Kanner, 1943), little work has investigated the 
particular types of anxiety common of autism, relative to amygdala structure. Juranek and 
colleagues (2006) found a positive correlation between general anxiety scores on the Child 
Behavior Checklist (CBCL; Achenbach, 1991) and right amygdala volume in children with ASD 
ages 3.7 – 14.7 years. Conversely, Corbett and colleagues (2009) suggested an interaction 
between smaller amygdala volumes, increased social anxiety, and age group in older children; 
and Nacewicz and colleagues (2006) have speculated social anxiety as a mediator between 
decreased amygdala volume and increased social impairments in adolescent and adult males with 
higher functioning ASD. 
Social Anxiety 
The prevalence of social anxiety in autism seems logical, given the social nature of ASD 
impairments. Moreover, increased social anxiety has been found to negatively correlate with 
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social behavioral impairments in youth with ASD (Bellini, 2004; Kleinhans et al., 2010). And as 
Ollendick, Oswald, Scahill, and White (2009) have noted, a high risk for developing social 
anxiety may root from the fact that many individuals with ASD are often uncomfortable or 
embarrassed about their impaired social functioning. Therefore, social impairments and anxiety 
may exacerbate one another. Because the distinction between autism-associated social 
impairments and anxiety-associated social impairments is often ambiguous in ASD, more 
research must be done on the neuroanatomical predictors of anxiety in ASD, as well as the types 
of anxiety that commonly occur.  
The goal of this study was to characterize the relationship between social anxiety and 
amygdala structure in autism, relative to other types of anxiety. In order to do this, I compared 
measurements of anxiety symptoms and amygdala volume in between youth with ASD and 
healthy controls. Participants ranged in age from 8-19 years: Ages at which amygdala volumes 
are believed to peak and anxiety is believed to worsen. Amygdala volume was measured using 
manual tracing methods on MRI, while anxiety was assessed by self-report surveys, measuring 
four major types of anxiety: physical symptoms, social anxiety, harm avoidance, and separation 
anxiety. 
To investigate the relationships between these factors, I established four main 
hypotheses. The first prediction was that between groups, participants with ASD would display 
significantly larger bilateral amygdala volumes relative to controls. Additionally, those in the 
ASD group would have significantly higher anxiety: Particularly social anxiety. These increased 
anxiety levels should also correlate positively with amygdala volumes. 
Drawing on previous work from Schumann and colleagues (2004), I also created groups 
of age for participants younger and older than 13 years. I predicted that group differences in 
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amygdala volume should interact with age group, in that larger amygdala volumes in ASD 
should remain significant in younger, non-adolescent participants only.  
Method 
Participants 
Ninety-five children and adolescents with ASD and 72 healthy controls participated in 
this study. Those with ASD were recruited through the University of Michigan Autism and 
Communication Disorders Center (UMACC), while healthy controls were recruited through 
advertisements and flyers. All participants with ASD were clinically diagnosed based on the 
Autism Diagnostic Observation Schedule (ADOS; Lord et al., 2000), and the Autism Diagnostic 
Interview-Revised (ADI-R; Le Couteur, Lord, & Rutter, 1994). Twenty-nine participants with 
ASD and two controls were removed from the sample after scoring < 85 in cognitive 
functioning. Additionally, one participant with ASD and one control quit the scan due to anxiety, 
two participants with ASD and three controls were unable to go into the scanner, seven 
participants with ASD and five controls had untraceable images, and 23 participants with ASD 
and six controls were excluded due to excessive head movement. The final sample size consisted 
of 33 individuals with ASD and 55 controls. Participants ranged in age from 8 to 19 years (M = 
14.19, SD = 2.76). Youth with ASD had a mean age of 13.53 years (SD = 2.29), while healthy 
controls had a mean age of 14.59 years (SD = 2.95). There were no significant differences in age, 
verbal IQ, and non-verbal IQ between groups (see Table 1). The Institutional Review Board 
approved all procedures, and parents and guardians signed consent/assent forms.  
Additionally, 14 individuals with ASD were on psychotropic medications. Three 
individuals were on selective serotonin reuptake inhibitors (SSRIs), eight were on stimulants for 
attention-deficit hyperactivity disorder (ADHD), three were on non-stimulant ADHD 
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medications, two were on anxiolytics, three were on antipsychotics, and four took a combination 
of medications (see Table 2).  
Materials 
IQ. To Measure verbal and non-verbal IQ, participants were administered Peabody 
Picture Vocabulary Tests (PPVT), Differential Ability Scales (DAS), Wechsler Intelligence 
Scale for Children, Stanford-Binet Intelligence Scales, and Ravens Progressive Matrices. Those 
who scored < 85 in cognitive functioning were excluded for study.  
Anxiety. To measure anxiety, participants completed the Multidimensional Anxiety 
Scale for Children, a 39-item self-report survey (MASC; March et al., 1997). MASC was chosen 
due to its noted internal consistency, as well as its discriminative reliability in characterizing four 
major factors of anxiety: physical symptoms, social anxiety, harm avoidance, and separation 
anxiety (March et al., 1997; Maddox, Schry, & White, 2012).  
Procedure 
Participants underwent a structural magnetic resonance imaging (MRI) scan using a 3-T 
GE Signa. High-resolution sagittal SPGR images were collected, consisting of 110 slices 1.4 mm 
thick (flip angle = 15°, FOV = 26 cm). All MRI images were saved and organized randomly to 
ensure I, along with two other raters, was blind to each participant’s diagnosis. Participants’ left 
and right amygdalae were identified using manual tracing methods on MRI analyzing software 
BRAINS2 (University of Iowa, Iowa City, Iowa). We reviewed previous literature, such as that 
of McMaster and colleagues (2008), to obtain a better understanding of manual tracing methods 
and the anatomical landmarks of amygdala morphometry. Beginning posteriorly, the amygdala 
was distinguished between the superiomedial portion of the temporal horn and the medial 
ambient gyrus (see Appendix). Once each amygdala was traced, the volume was calculated 
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through BRAINS2. Each rater attained inter-rater reliability coefficients > 0.9 in both 
hemispheres form 10 randomly selected scans before the remaining 78 images were analyzed. 
Results 
Amygdala Volume 
An independent samples t-test conducted using SPSS (SPSS Inc., Chicago, IL) indicated 
a significant group difference in left amygdala volume, (t(86) = -3.58, p < .01), in that 
participants with ASD displayed larger volumes (M = 1.30, SD = .27), than controls (M = 1.12, 
SD = .19). There was a similar group difference in the right amygdala, (t(86) = -3.23, p < .01), 
where again, the ASD group displayed significantly larger volumes (M = 1.32, SD = .26), 
compared to controls (M = 1.16, SD = .22; see Table 1, Figure 1). 
Anxiety 
 Another independent samples t-test revealed significant group differences in social 
anxiety (t(76) = -2.92, p < .01) and separation anxiety scores (t(76) = -3.04, p < .01). Participants 
in the ASD group had higher social anxiety scores (M = 11.18, SD = 6.46), than controls (M = 
7.50, SD = 4.60). Additionally, those with ASD had separation anxiety scores (M = 8.36, SD = 
4.60), relative to controls (M = 5.52, SD = 3.54; see Table 1, Figure 2). 
 There was a significant interaction between group and social anxiety scores in predicting 
left (F(2, 75) = 11.34, p < .01), and right amygdala volumes (F(2, 75) = 7.04, p < .01; see Table 
3). This interaction was driven by a positive correlation between social anxiety and left amygdala 
volume (r = .455, p < .05; see Figure 4), as well as right amygdala volume (r = .402, p < .05) in 
the ASD group. Thus, participants with higher levels of social anxiety were more likely to have 
larger amygdala volumes. Separation anxiety, however, did not share a significant relationship 
with either left (r = .334, p = .082) or right amygdala volumes (r = .256, p = .188). No significant 
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correlations between amygdala volume and anxiety were evident in controls (see Table 4, Figure 
3). 
Age  
 Age did not correlate significantly with left amygdala volume, right amygdala volume, or 
any anxiety score. However, I created age groups to further investigate relationships between 
group, social anxiety, and amygdala volume within late childhood and adolescence separately. 
Participants were split into age groups younger than 13 years (n = 30) and older than 13 years (n 
= 57). I then ran an independent samples t-test to reassess group differences in amygdala volume 
within each age group. In younger participants, those with ASD had significantly larger left 
amygdala volumes (M = 1.30, SD = 0.31), relative to controls (M = 1.10, SD = 0.16; t(29) = -
2.272, p < .05). In the older age group, participants with ASD also had larger left amygdala 
volumes (M = 1.30, SD = 0.24), (t(54) = -2.733, p < .01), compared to controls (M = 1.13, SD = 
0.21), and additionally, larger right amygdala volumes (M = 1.34, SD = 0.29), relative to controls 
(M = 1.14, SD = 0.20; t(54) = -2.997, p < .01; see Table 5). 
There was also a significant interaction between group, age group, social anxiety in 
predicting left (F(4, 72) = 5.58, p < .01) and right amygdala volumes (F(4, 72) = 3.80, p < .01).  
A bivariate correlational analysis was generated again to assess the relationships between anxiety 
and amygdala volume in each age group. In younger individuals with ASD, there was a 
significant positive correlation between social anxiety scores and left amygdala volume (r = 
.583, p < .05; see Figure 5). There were no significant relationships between social anxiety and 
amygdala volume in older individuals with ASD, however, there was a positive correlation 
between social anxiety and age (r = .588, p < .05; see Figure 6). No significant correlations were 
evident in controls of any age group.  




While comparing mean amygdala volumes between medicated and non-medicated 
participants, those on medication displayed significantly larger left (t(86) = -2.750, p < .01) and 
right amygdala volumes (t(86) = -2.189, p < .05). However, when comparing medicated and non-
medicated participants’ volumes within the ASD group, there were no significant differences. 
Medication significantly interacted in the relationship between group and social anxiety (F(1, 77) 
= 14.848, p < .01), as well as separation anxiety (F(1, 77) = 15.459, p < .01).  Medicated 
participants had significantly higher levels of social anxiety, relative to non-medicated 
participants (t(73) = -2.158, p < .05). Within the ASD group, medicated participants displayed 
significantly higher levels of social anxiety (t(26) = -2.250, p < .05) and separation anxiety (t(73) 
= -2.371, p < .05).  
To investigate whether the presence of medicated participants explained the results of this 
study, those taking medication were excluded and the previous analyses were run. Because there 
were no controls on medication, findings exclusively within the control group were unaffected. 
Group X social anxiety X amygdala volume interactions, as well as group X age group X social 
anxiety X amygdala volume interactions, were no longer significant. However, Significant 
differences in left (t(72) = -2.647, p < .05) and right amygdala volume (t(72) = -2.442, p < .05), 
between the ASD group and controls remained. In the ASD group, left amygdala volume still 
positively correlated with social anxiety (r = .487, p < .05), and additionally with physical 
symptoms (r = .563, p < .05). There was also a positive correlation between right amygdala 
volume and social anxiety (r = .585, p < .05), and physical symptoms (r = .633, p < .05) as well.  
Discussion 
Main Findings 
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 As predicted, participants with ASD displayed significantly larger bilateral amygdala 
volumes, as well as a significantly higher amount of anxiety. Left and right amygdala volumes 
positively correlated with social anxiety scores in the ASD group, while no significant 
relationships were evident in controls. These results were consistent with previous studies of 
ASD, finding increased amygdala volume in youth (Nordahl et al., 2012; Sparks et al., 2002; 
Buitelaar, Groen, Teluij, & Tendolkar, 2010), as well as increased anxiety (Ollendick, Oswald, 
Scahill, & White, 2009; Kuusikko et al., 2008; Kleinhans et al., 2010; Juranek et al., 2006). 
Juranek and colleagues (2006) also found a positive relationship between anxiety and right 
amygdala volume using the CBCL; although a limitation this method is that it does not 
exclusively measure anxiety, nor does it signify the type of anxiety measured. An advantage to 
using MASC is that the survey solely measures symptoms of pediatric anxiety, as well as 
specific anxiety traits. Because of this, I was able to identify heightened social anxiety as a 
predictor of increased bilateral amygdala volume in ASD. To the best of my knowledge, this 
study is the first to identify this relationship.  
Furthermore, this study hypothesized that group differences in amygdala volume would 
interact with age group, in that differences in volume between ASD and control groups would 
only remain significant in younger participants. Contrary to these expectations, older participants 
displayed an even larger discrepancy in amygdala volumes. A possible explanation as to why 
these results differ from that of Schumann and colleagues (2004) may rely on the relatively 
smaller number of participants with ASD. When those with ASD were split into age groups, 
there were only 15 individuals younger than 13 years and 18 individuals older than 13 years. 
Because of these smaller group sizes, it is possible that participants with ASD in each age group 
were not an accurate representation of the ASD youth population.  




Additionally, many participants with ASD were excluded due to verbal and nonverbal IQ 
scores < 85. Because Schumann and colleagues (2004) included a wide distribution of ASD 
diagnosis types, their study included 19 individuals with IQ scores < 70. My exclusion of 
participants with lower functioning autism presents a possible limitation to this study. Participant 
ASD diagnoses include: Autistic disorder (AD), high-functioning autism (HFA), and pervasive-
developmental disorder- not otherwise specified (PDD-NOS). The significant amount of 
participants with higher functional abilities may also lead to a larger amount of anxiety in the 
ASD sample. As suggested by Attwood (2000), individuals with higher functioning ASD and 
Asperger’s syndrome may be significantly more anxious than those with lower functioning ASD, 
due to an increased awareness of their impairments during social interactions. Thus, future 
investigations focusing on social anxiety in ASD may benefit by recruiting from a diverse array 
of functional abilities. 
When medicated participants were excluded, group differences in amygdala volume 
within younger participants were no longer significant. These results provide many implications 
on the role of psychotropic medication in amygdala volume-anxiety interactions in ASD. 
Findings of increased social anxiety in medicated participants are not surprising, as many 
medications were prescribed to alleviate anxiety symptoms (e.g., SSRIs, anxiolytics). It is also 
possible, perhaps, that amygdala volume did not decrease in adolescents with ASD due to the 
inhibitory or excitatory effects their medications may hold on amygdala activity.  
Hyperactivity of the amygdala has been observed individuals with ASD while viewing 
emotional faces (Dalton et al., 2005; Weng et al., 2011; Monk et al., 2010). Decreased amygdala 
habituation, the prolonged activation of the amygdala in response to facial stimuli, has also been 
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suggested (Kleinhans et al., 2009), and as of recently, found to correlate to the degree of social 
impairments observed in ASD (Carrasco, Lord, Monk, Swartz, & Wiggins, 2013). In line with 
these observations, amygdala hyperactivity has been proposed as an indication of aversive 
reactions to emotional faces, evoking an increased emotional response (Dalton, et al., 2005; 
Chilvers, Corden, & Skuse, 2007). As speculated by Buitelaar, Groen, Teluij, and Tendolkar 
(2010), stress and anxiety in children with ASD may lead to increased activity in the amygdala. 
In turn, this functional increase may eventually lead to excitotoxic effects as they age into 
adulthood. Post-mortem findings of unusually small and densely packed amygdala neurons in 
ASD further support this theory (Bauman & Kemper, 1993). Still, the exact mechanism of these 
abnormalities remains unknown. 
Finally, an assessment of accuracy of child-reported anxiety measures suggests another 
possible limitation to this study. Maddox, Schry, and White (2012) found that adolescents using 
MASC tended to significantly underreport their anxiety levels in comparison to parent-reported 
MASC and clinical analyses. Future studies measuring anxiety in ASD may receive more 
accurate data from utilizing both child and parent-reporting techniques. 
Conclusions 
The results of this study suggest that within ASD, larger amygdala volume is associated 
with a higher degree of social anxiety. This relationship was also influenced by age. Further 
investigations relating these interactions to particular ASD diagnoses, as well as additional 
measures of anxiety, social behavior, and amygdala activity may help distinguish possible 
underlying mechanisms of ASD impairments. 
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 ASD  Control  
Measure n Mean (SD) n Mean (SD) Group differences 
Age (years) 33 13.53 (2.29) 54 14.59 (2.95) t(85) = 1.78, p > .05 
Verbal IQ 33 114.21 (20.82) 55 113.80 (13.48) t(86) = -.11, p > .05 
Nonverbal IQ 32 107.56 (19.28) 52 103.04 (12.13) t(82) = -1.32, p > .05 
Physical symptoms 28 8.96 (7.02) 50 6.38 (4.54) t(76) = -1.97, p > .05 
Social anxiety 28 11.18 (6.46) 50 7.50 (4.60) t(76) = -2.92, p < .01* 
Harm avoidance 28 13.21 (5.36) 50 11.56 (4.73) t(76) = -1.41, p > .05 
Separation anxiety 28 8.36 (4.6) 50 5.52 (3.54) t(76) = -3.04, p < .01* 
LA volume (cm3) 33 1.30 (.27) 55 1.12 (.19) t(86) = -3.58, p < .01* 
RA volume (cm3) 33 1.32 (.26) 55 1.16 (.22) t(86) = -3.23, p < .01* 
Note. LA = left amygdala; RA = right amygdala. Physical symptoms, social anxiety, harm 
avoidance, and separation anxiety are subscales of the Multidimensional Anxiety Scale for 
Children (MASC; March et al., 1997). Age was missing for one control. Nonverbal IQ was 
missing for one participant with ASD and three controls. Five participants with ASD and five 
controls were missing MASC scores.  
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Table 2.  
Medication  
 ASD Control Total 
Medication type n % n % n % 
Any 14 42.4 NA NA 14 15.9 
SSRI 3 9.1   3 3.4 
Stimulant, ADHD 8 24.2   8 9.1 
Non-stimulant, ADHD 3 9.1   3 3.4 
Anxiolytic 2 6.1   2 2.3 
Antipsychotic 3 9.1   3 3.4 
Combination 4 12.1   4 4.5 
Note. SSRI = selective serotonin reuptake inhibitor; ADHD = attention deficit hyperactivity 















Interactions in Predicting Left and Right Amygdala Volume 
Dependent variable 
Group * social anxiety  Group * age group * social anxiety 
R2  F (2, 75)  R2 F (4, 72) 
Left amygdala volume .232 11.338**  .194 5.582** 
Right amygdala volume .158 7.038**  .128 3.787** 
Note. There was a significant group X social anxiety interaction, as well as a group X age group 
X social anxiety interaction in predicting bilateral amygdala volumes.  



















Bivariate Correlations: Amygdala Volume, Anxiety, and Age Between Groups 
 ASD Control 
Measure LA RA LA RA 
Physical Symptoms .364 .373 -.115 -.110 
Social anxiety .455* .402* .021 -.186 
Harm avoidance .345 .324 -.170 -.229 
Separation anxiety .334 .256 -.104 -.216 
Age .173 .204 .181 .080 
Note. LA = left amygdala; RA = right amygdala. 
Participants with ASD displayed positive correlations between social anxiety and left amygdala 
volume, as well as right amygdala volume.  














Group Differences in Amygdala Volume (cm3), Divided by Age 
 
Ages < 13 (years) Ages > 13 (years) 
 ASD 
(n = 15) 
Control 
(n = 38) 
 ASD 
(n = 18) 
Control 
(n = 38)	  
 
Measure M (SD) M (SD) t(29) M (SD) M (SD) t(54) 









1.14 (.20) -3.00** 
Note. When participants were divided into age groups, younger participants displayed a 
significant difference in left amygdala volume between ASD and control groups. This difference 
did not remain significant in the right hemisphere. Moreover, participants older than 13 years 
displayed a significant difference in both left and right amygdala volumes between ASD and 
control groups. 
*Difference is significant at p < .05 















Figure 1. Group differences in amygdala volume. This bar graph illustrates the significantly 
lager mean volumes in the ASD group for both the left and right amygdala. Standard errors are 

































Figure 2. Group differences in anxiety. Although the ASD group had higher mean scores in 
every anxiety category, these group differences were only significant between social anxiety and 


































Figure 3. Left amygdala volume (cm3) and social anxiety. This scatter plot compares the 
relationships between left amygdala volume and MASC social anxiety sub scores. No significant 

































Figure 5. Age group differences in the relationship between social anxiety and left amygdala 
volume (cm3). In younger participants with ASD, social anxiety correlated positively with left 
amygdala volume. There were no significant relationships between social anxiety and volume in 
older participants with ASD, nor were there in controls of any age group. 
*R2 = .064 
**R2 = .009 
***R2 = .343 
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Figure 6. Age group differences in the relationship between social anxiety and age. In older 
participants with ASD, social anxiety correlated positively with age. There were no significant 
relationships between social anxiety and age in younger participants with ASD, nor were there in 
controls of any age group. 
*R2 = .124 
**R2 < .001 
***R2 = .009 
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A sample window of the MRI analyzing software BRAINS2, displaying a left amygdala tracing. 
Raters traced on a coronal plane, moving rostrally, as illustrated in the bottom left.  
